Reaction
Jc Polyomavirus Test Positive reporting signals
As of the last recalculation, Jc Polyomavirus Test Positive appears in 1,162 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is OCRELIZUMAB (PRR 302.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ocrelizumab | 552 | 302.8 | 305.5 |
| Fingolimod Hcl | 276 | 74.7 | 74.9 |
| Ofatumumab | 48 | 26.9 | 27.0 |
| Cladribine | 14 | 26.4 | 26.4 |
| Siponimod | 13 | 26.4 | 26.4 |
| Dalfampridine | 77 | 20.5 | 20.5 |
| Teriflunomide | 48 | 19.8 | 19.8 |
| Baclofen | 83 | 18.5 | 18.5 |
| Glatiramer Acetate | 55 | 17.3 | 17.3 |
| Modafinil | 26 | 14.7 | 14.7 |
| Ozanimod Hydrochloride | 6 | 13.0 | 13.0 |
| Polatuzumab Vedotin | 7 | 12.9 | 12.9 |
| Interferon Beta-1B | 12 | 11.3 | 11.3 |
| Tizanidine | 14 | 10.6 | 10.6 |
| Bendamustine Hydrochloride | 7 | 10.5 | 10.5 |
| Amantadine | 9 | 10.5 | 10.5 |
| Natalizumab | 97 | 10.3 | 10.3 |
| Dimethyl Fumarate | 66 | 10.1 | 10.1 |
| Peginterferon Beta-1A | 5 | 6.9 | 6.9 |
| Diroximel Fumarate | 4 | 6.0 | 6.0 |
| Axicabtagene Ciloleucel | 3 | 5.5 | 5.5 |